The Journal of Urology® Volumes 201/202 Home Study Course (2019)
Most Comprehensive and Affordable Self-study CME Product!
Make the most of your Journal of Urology® Subscription
Developed by a team of educators, academicians, and clinicians, this valuable home study activity will enhance your knowledge of urology and improve performance as well as patient care at your convenience. For just $2.50 per credit, the Home Study program is designed to provide urologists and residents affordable access to the most recent developments and techniques in urology while reading The Journal®.
Each month includes 5 clinically-relevant, selected articles with a corresponding online test for each of the 12 issues of The Journal®.
The American Urological Association designates this enduring material for a maximum of 24 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This Home Study Course is available only to subscribers of The Journal of Urology® and includes volumes 201 and 202.
The 2016, 2017, and 2018 CME posttests are available online. The 2019 posttests will be posted online as they become available.
Target Audience
- Practicing Urologists
- American Board of Urology (ABU) candidates
- Residents
Learning Objectives
After completing each lesson, the participants should be able to:
- Assess their knowledge of urology
- Demonstrate an increased knowledge base of urology
- Apply the increased knowledge to improve quality of patient care
Disclosures
(Individuals in control of the content. All individuals with their respective disclosures listed in this document are planners. Individual authors’ disclosures are located with their articles in each issue of The Journal of Urology®.)
The Journal of Urology® Editorial Board
Name | Company | Role |
Anthony Atala, MD | Plureon Inc | Leadership Position |
D Duane Baldwin, MD | Olympus Corporation | Consultant or Advisor |
Bard Medical Divison | Consultant or Advisor | |
DARRT | Leadership Position | |
StepLite | Leadership Position | |
Pfizer | Investment Interest | |
Peter Colin Black, MD | GenomeDx Biosciences Inc | Consultant or Advisor, Scientific Study or Trial |
Janssen | Consultant or Advisor, Meeting Participant or Lecturer, Scientific Study or Trial | |
Astellas | Consultant or Advisor, Meeting Participant or Lecturer, Scientific Study or Trial | |
Amgen | Consultant or Advisor, Meeting Participant or Lecturer, Scientific Study or Trial | |
Sitka | Consultant or Advisor | |
AbbVie | Consultant or Advisor, Meeting Participant or Lecturer, Scientific Study or Trial | |
Bristol Myers Squibb | Consultant or Advisor | |
UroGen | Consultant or Advisor | |
European Urology Focus | Health Publishing | |
Sanofi | Consultant or Advisor | |
Pfizer | Meeting Participant or Lecturer | |
PLOS ONE | Health Publishing | |
BMC Urology | Health Publishing | |
Merck | Consultant or Advisor | |
iProgen | Scientific Study or Trial | |
Bayer | Consultant or Advisor | |
Biosyent | Consultant or Advisor | |
RedLeaf Medical | Meeting Participant or Lecturer | |
Biocancell | Consultant or Advisor | |
Roche/Genentech | Consultant or Advisor, Scientific Study or Trial | |
World Journal of Urology | Health Publishing | |
Urologic Oncology | Health Publishing | |
Bladder Cancer | Health Publishing | |
Rodney Henry Breau, MD | AUA - Journal of Urology | Health Publishing |
Mark Patrick Cain, MD | ||
Toby C. Chai, MD | Avadel | Consultant or Advisor |
Karim Chamie ,MD | Altor | Leadership Position |
Urogen Pharma | Consultant or Advisor | |
Astrazenica | Consultant or Advisor, Meeting Participant or Lecturer | |
Craig Vance Comiter, MD | zenflow | Scientific Study or Trial |
Avails medical | Consultant or Advisor | |
Neuspera | Consultant or Advisor | |
BE technologies | Scientific Study or Trial | |
BE Technology | Scientific Study or Trial | |
Siamak Daneshmand, MD | Photocure | Consultant or Advisor, Meeting Participant or Lecturer, Scientific Study or Trial |
Taris | Consultant or Advisor | |
Pacific Edge | Consultant or Advisor | |
John Warren Davis, MD | Genprobe | Scientific Study or Trial |
Janssen | Scientific Study or Trial | |
GenomeDx | Scientific Study or Trial | |
British Journal of Urology International | Health Publishing | |
Intuitive | Consultant or Advisor | |
Ithaar H. Derweesh, M.D. | GlaxoSmithKline, Inc. | Scientific Study or Trial |
Pfizer | Scientific Study or Trial | |
Novartis AG | Scientific Study or Trial | |
Genentech Inc | Consultant or Advisor | |
Scott E. Eggener, MD | Profound Medical | Consultant or Advisor |
Genomic Health | Scientific Study or Trial | |
MDx Health | Consultant or Advisor, Meeting Participant or Lecturer, Scientific Study or Trial | |
Opko Health | Scientific Study or Trial | |
janssen | Consultant or Advisor, Meeting Participant or Lecturer | |
Sophiris | Consultant or Advisor | |
Insightec | Consultant or Advisor | |
World Journal of Urology | Health Publishing | |
Journal of Urology | Health Publishing | |
Canadian Journal of Urology | Health Publishing | |
ASCO | Health Publishing, Meeting Participant or Lecturer | |
Khurshid R. Ghani, M.D. | Boston Scientific Corporation | Consultant or Advisor, Scientific Study or Trial |
Blue Cross Blue Shield of Michigan | Scientific Study or Trial | |
Lumenis | Consultant or Advisor, Meeting Participant or Lecturer | |
Martin Gross, M.D. | Coloplast | Consultant or Advisor, Scientific Study or Trial |
Jason C. Hedges, MD, PhD | ||
Wayne John G. Hellstrom, MD | Endo | Consultant or Advisor, Meeting Participant or Lecturer, Scientific Study or Trial |
Theralogix | Leadership Position | |
Coloplast | Consultant or Advisor, Meeting Participant or Lecturer | |
NIH | Leadership Position | |
New England Research Institutes, Inc | Other | |
Abbvie | Consultant or Advisor | |
Pfizer | Consultant or Advisor | |
Allergan | Consultant or Advisor | |
Boston Scientific | Consultant or Advisor | |
Virility | Consultant or Advisor | |
SuperiorVas | Consultant or Advisor | |
Futura | Consultant or Advisor | |
Ashish M. Kamat, MD | FKD | Scientific Study or Trial |
Photocure | Consultant or Advisor, Meeting Participant or Lecturer, Scientific Study or Trial | |
Abbott Molecular | Consultant or Advisor | |
Theralase | Consultant or Advisor | |
Merck | Consultant or Advisor, Scientific Study or Trial | |
BMS | Consultant or Advisor | |
MDxHealth | Consultant or Advisor | |
Melissa Rae Kaufman, MD, PHD | Boston Scientific | Consultant or Advisor, Other |
Cook Myosite | Other | |
Valencia Technologies | Scientific Study or Trial | |
Journal of Urology | Health Publishing | |
Stephanie J. Kielb, M.D. | ||
Simon Kim, MD | ||
Laurence H. Klotz, MD | Astellas | Meeting Participant or Lecturer, Scientific Study or Trial |
Janssen | Meeting Participant or Lecturer, Scientific Study or Trial | |
MiRScientific | Leadership Position | |
Tolmar | Consultant or Advisor | |
Badrinath R. Konety, MD, MBA | Photocure Inc | Consultant or Advisor, Scientific Study or Trial |
Genomic Health | Scientific Study or Trial | |
MDX Health | Consultant or Advisor | |
FKD Therapeutics | Scientific Study or Trial | |
Bristol Myers Squibb | Consultant or Advisor, Scientific Study or Trial | |
Taris Biomedical | Consultant or Advisor, Scientific Study or Trial | |
Boston Scientific Corp | Consultant or Advisor | |
Merck Inc | Scientific Study or Trial | |
Jaime Landman, MD | Cook Urological | Consultant or Advisor, Owner, Product Development |
Galil Medical | Consultant or Advisor | |
CONMED | Consultant or Advisor | |
Auris | Consultant or Advisor, Investment Interest | |
Vitaly Margulis, M.D. | Jannsen Biotech | Consultant or Advisor, Meeting Participant or Lecturer |
Pfizer | Meeting Participant or Lecturer | |
Ferring Pharma | Consultant or Advisor, Meeting Participant or Lecturer | |
MDXHealth | Consultant or Advisor, Meeting Participant or Lecturer | |
Genomic Health | Meeting Participant or Lecturer | |
Kevin Thomas McVary, MD, FACS | Astellas | Scientific Study or Trial |
NIDDK | Scientific Study or Trial | |
AMS/Boston Scientific | Consultant or Advisor, Meeting Participant or Lecturer, Scientific Study or Trial | |
Merck | Consultant or Advisor | |
Olympus | Consultant or Advisor, Meeting Participant or Lecturer | |
UroNext | Leadership Position, Scientific Study or Trial, Owner, Product Development | |
SRS Medical Systems | Health Publishing, Consultant or Advisor, Scientific Study or Trial | |
Maxwell V. Meng, MD | AUA | Health Publishing |
Urologic Oncology (Journal) | Health Publishing | |
Bristol Myers Squibb | Consultant or Advisor | |
David Christopher Miller, MD, MPH | Blue Cross Blue Shield of Michigan | Other |
National Cancer Institute | Scientific Study or Trial | |
Nicole Lara Miller, MD | Boston Scientific Corporation | Consultant or Advisor, Meeting Participant or Lecturer |
Practical Reviews In Urology | Health Publishing | |
Joel Byron Nelson, MD | ||
Vernon M. Pais Jr., MD | Clinical Nephrology | Health Publishing |
John Luther Phillips, MD | ||
Phillip M. Pierorazio, MD | Testicular Cancer Awareness Foundation | Leadership Position |
National Comprehensive Cancer Network | Consultant or Advisor | |
Urogen Pharmaceuticals | Consultant or Advisor, Scientific Study or Trial | |
Deborah F. Polly | ||
Sanoj Punnen, MD | Genome Dx | Meeting Participant or Lecturer |
OPKO Diagnostics | Scientific Study or Trial | |
OPKO Diagnostics | Meeting Participant or Lecturer | |
Jay D. Raman, MD | American Kidney Stone Management | Investment Interest |
MDx Health | Scientific Study or Trial | |
Urogen Pharma | Consultant or Advisor, Scientific Study or Trial | |
Bradley Fields Schwartz, MD | Cook Medical | Meeting Participant or Lecturer |
Olympus | Meeting Participant or Lecturer | |
Ojas Shah, MD | Boston Scientific | Consultant or Advisor, Meeting Participant or Lecturer |
Elsevier | Health Publishing | |
American Urological Association | Meeting Participant or Lecturer, Other | |
Bristol Myers Squibb | Investment Interest | |
Applaud Medical | Consultant or Advisor | |
Coloplast | Consultant or Advisor, Meeting Participant or Lecturer | |
NJ Kidney Stone Center | Investment Interest | |
Glaxo Smith Kline | Investment Interest | |
Novartis | Investment Interest | |
Joseph A. Smith Jr., MD | ||
Angela M. Smith, MD, FACS, MS | AHRQ | Scientific Study or Trial |
PCORI | Scientific Study or Trial | |
Photocure | Consultant or Advisor | |
Kevan A. Sternberg, MD | The Journal of Urology | Leadership Position |
John T. Stoffel, MD | Uroplasty | Scientific Study or Trial |
PCORI | Scientific Study or Trial | |
Journal of urology | Leadership Position | |
Department of Defense | Scientific Study or Trial | |
Ipsen | Scientific Study or Trial | |
Quoc-Dien Trinh, MD | Janssen | Meeting Participant or Lecturer |
Mark D. Tyson, MD | ||
Ramakrishna Venkatesh, MD | Retrophin Inc | Consultant or Advisor |
Julian Hsin-Cheng Wan, MD | Allergan | Scientific Study or Trial |
Journal of Urology | Health Publishing | |
Name | Company | Role |
Anthony Atala, MD | Plureon Inc | Leadership Position |
D Duane Baldwin, MD | Olympus Corporation | Consultant or Advisor |
Bard Medical Divison | Consultant or Advisor | |
DARRT | Leadership Position | |
StepLite | Leadership Position | |
Pfizer | Investment Interest | |
Peter Colin Black, MD | GenomeDx Biosciences Inc | Consultant or Advisor, Scientific Study or Trial |
Janssen | Consultant or Advisor, Meeting Participant or Lecturer, Scientific Study or Trial | |
Astellas | Consultant or Advisor, Meeting Participant or Lecturer, Scientific Study or Trial | |
Amgen | Consultant or Advisor, Meeting Participant or Lecturer, Scientific Study or Trial | |
Sitka | Consultant or Advisor | |
AbbVie | Consultant or Advisor, Meeting Participant or Lecturer, Scientific Study or Trial | |
Bristol Myers Squibb | Consultant or Advisor | |
UroGen | Consultant or Advisor | |
European Urology Focus | Health Publishing | |
Sanofi | Consultant or Advisor | |
Pfizer | Meeting Participant or Lecturer | |
PLOS ONE | Health Publishing | |
BMC Urology | Health Publishing | |
Merck | Consultant or Advisor | |
iProgen | Scientific Study or Trial | |
Bayer | Consultant or Advisor | |
Biosyent | Consultant or Advisor | |
RedLeaf Medical | Meeting Participant or Lecturer | |
Biocancell | Consultant or Advisor | |
Roche/Genentech | Consultant or Advisor, Scientific Study or Trial | |
World Journal of Urology | Health Publishing | |
Urologic Oncology | Health Publishing | |
Bladder Cancer | Health Publishing | |
Rodney Henry Breau, MD | AUA - Journal of Urology | Health Publishing |
Mark Patrick Cain, MD | ||
Toby C. Chai, MD | Avadel | Consultant or Advisor |
Karim Chamie ,MD | Altor | Leadership Position |
Urogen Pharma | Consultant or Advisor | |
Astrazenica | Consultant or Advisor, Meeting Participant or Lecturer | |
Craig Vance Comiter, MD | zenflow | Scientific Study or Trial |
Avails medical | Consultant or Advisor | |
Neuspera | Consultant or Advisor | |
BE technologies | Scientific Study or Trial | |
BE Technology | Scientific Study or Trial | |
Siamak Daneshmand, MD | Photocure | Consultant or Advisor, Meeting Participant or Lecturer, Scientific Study or Trial |
Taris | Consultant or Advisor | |
Pacific Edge | Consultant or Advisor | |
John Warren Davis, MD | Genprobe | Scientific Study or Trial |
Janssen | Scientific Study or Trial | |
GenomeDx | Scientific Study or Trial | |
British Journal of Urology International | Health Publishing | |
Intuitive | Consultant or Advisor | |
Ithaar H. Derweesh, M.D. | GlaxoSmithKline, Inc. | Scientific Study or Trial |
Pfizer | Scientific Study or Trial | |
Novartis AG | Scientific Study or Trial | |
Genentech Inc | Consultant or Advisor | |
Scott E. Eggener, MD | Profound Medical | Consultant or Advisor |
Genomic Health | Scientific Study or Trial | |
MDx Health | Consultant or Advisor, Meeting Participant or Lecturer, Scientific Study or Trial | |
Opko Health | Scientific Study or Trial | |
janssen | Consultant or Advisor, Meeting Participant or Lecturer | |
Sophiris | Consultant or Advisor | |
Insightec | Consultant or Advisor | |
World Journal of Urology | Health Publishing | |
Journal of Urology | Health Publishing | |
Canadian Journal of Urology | Health Publishing | |
ASCO | Health Publishing, Meeting Participant or Lecturer | |
Khurshid R. Ghani, M.D. | Boston Scientific Corporation | Consultant or Advisor, Scientific Study or Trial |
Blue Cross Blue Shield of Michigan | Scientific Study or Trial | |
Lumenis | Consultant or Advisor, Meeting Participant or Lecturer | |
Martin Gross, M.D. | Coloplast | Consultant or Advisor, Scientific Study or Trial |
Jason C. Hedges, MD, PhD | ||
Wayne John G. Hellstrom, MD | Endo | Consultant or Advisor, Meeting Participant or Lecturer, Scientific Study or Trial |
Theralogix | Leadership Position | |
Coloplast | Consultant or Advisor, Meeting Participant or Lecturer | |
NIH | Leadership Position | |
New England Research Institutes, Inc | Other | |
Abbvie | Consultant or Advisor | |
Pfizer | Consultant or Advisor | |
Allergan | Consultant or Advisor | |
Boston Scientific | Consultant or Advisor | |
Virility | Consultant or Advisor | |
SuperiorVas | Consultant or Advisor | |
Futura | Consultant or Advisor | |
Ashish M. Kamat, MD | FKD | Scientific Study or Trial |
Photocure | Consultant or Advisor, Meeting Participant or Lecturer, Scientific Study or Trial | |
Abbott Molecular | Consultant or Advisor | |
Theralase | Consultant or Advisor | |
Merck | Consultant or Advisor, Scientific Study or Trial | |
BMS | Consultant or Advisor | |
MDxHealth | Consultant or Advisor | |
Melissa Rae Kaufman, MD, PHD | Boston Scientific | Consultant or Advisor, Other |
Cook Myosite | Other | |
Valencia Technologies | Scientific Study or Trial | |
Journal of Urology | Health Publishing | |
Stephanie J. Kielb, M.D. | ||
Simon Kim, MD | ||
Laurence H. Klotz, MD | Astellas | Meeting Participant or Lecturer, Scientific Study or Trial |
Janssen | Meeting Participant or Lecturer, Scientific Study or Trial | |
MiRScientific | Leadership Position | |
Tolmar | Consultant or Advisor | |
Badrinath R. Konety, MD, MBA | Photocure Inc | Consultant or Advisor, Scientific Study or Trial |
Genomic Health | Scientific Study or Trial | |
MDX Health | Consultant or Advisor | |
FKD Therapeutics | Scientific Study or Trial | |
Bristol Myers Squibb | Consultant or Advisor, Scientific Study or Trial | |
Taris Biomedical | Consultant or Advisor, Scientific Study or Trial | |
Boston Scientific Corp | Consultant or Advisor | |
Merck Inc | Scientific Study or Trial | |
Jaime Landman, MD | Cook Urological | Consultant or Advisor, Owner, Product Development |
Galil Medical | Consultant or Advisor | |
CONMED | Consultant or Advisor | |
Auris | Consultant or Advisor, Investment Interest | |
Vitaly Margulis, M.D. | Jannsen Biotech | Consultant or Advisor, Meeting Participant or Lecturer |
Pfizer | Meeting Participant or Lecturer | |
Ferring Pharma | Consultant or Advisor, Meeting Participant or Lecturer | |
MDXHealth | Consultant or Advisor, Meeting Participant or Lecturer | |
Genomic Health | Meeting Participant or Lecturer | |
Kevin Thomas McVary, MD, FACS | Astellas | Scientific Study or Trial |
NIDDK | Scientific Study or Trial | |
AMS/Boston Scientific | Consultant or Advisor, Meeting Participant or Lecturer, Scientific Study or Trial | |
Merck | Consultant or Advisor | |
Olympus | Consultant or Advisor, Meeting Participant or Lecturer | |
UroNext | Leadership Position, Scientific Study or Trial, Owner, Product Development | |
SRS Medical Systems | Health Publishing, Consultant or Advisor, Scientific Study or Trial | |
Maxwell V. Meng, MD | AUA | Health Publishing |
Urologic Oncology (Journal) | Health Publishing | |
Bristol Myers Squibb | Consultant or Advisor | |
David Christopher Miller, MD, MPH | Blue Cross Blue Shield of Michigan | Other |
National Cancer Institute | Scientific Study or Trial | |
Nicole Lara Miller, MD | Boston Scientific Corporation | Consultant or Advisor, Meeting Participant or Lecturer |
Practical Reviews In Urology | Health Publishing | |
Joel Byron Nelson, MD | ||
Vernon M. Pais Jr., MD | Clinical Nephrology | Health Publishing |
John Luther Phillips, MD | ||
Phillip M. Pierorazio, MD | Testicular Cancer Awareness Foundation | Leadership Position |
National Comprehensive Cancer Network | Consultant or Advisor | |
Urogen Pharmaceuticals | Consultant or Advisor, Scientific Study or Trial | |
Deborah F. Polly | ||
Sanoj Punnen, MD | Genome Dx | Meeting Participant or Lecturer |
OPKO Diagnostics | Scientific Study or Trial | |
OPKO Diagnostics | Meeting Participant or Lecturer | |
Jay D. Raman, MD | American Kidney Stone Management | Investment Interest |
MDx Health | Scientific Study or Trial | |
Urogen Pharma | Consultant or Advisor, Scientific Study or Trial | |
Bradley Fields Schwartz, MD | Cook Medical | Meeting Participant or Lecturer |
Olympus | Meeting Participant or Lecturer | |
Ojas Shah, MD | Boston Scientific | Consultant or Advisor, Meeting Participant or Lecturer |
Elsevier | Health Publishing | |
American Urological Association | Meeting Participant or Lecturer, Other | |
Bristol Myers Squibb | Investment Interest | |
Applaud Medical | Consultant or Advisor | |
Coloplast | Consultant or Advisor, Meeting Participant or Lecturer | |
NJ Kidney Stone Center | Investment Interest | |
Glaxo Smith Kline | Investment Interest | |
Novartis | Investment Interest | |
Joseph A. Smith Jr., MD | ||
Angela M. Smith, MD, FACS, MS | AHRQ | Scientific Study or Trial |
PCORI | Scientific Study or Trial | |
Photocure | Consultant or Advisor | |
Kevan A. Sternberg, MD | The Journal of Urology | Leadership Position |
John T. Stoffel, MD | Uroplasty | Scientific Study or Trial |
PCORI | Scientific Study or Trial | |
Journal of urology | Leadership Position | |
Department of Defense | Scientific Study or Trial | |
Ipsen | Scientific Study or Trial | |
Quoc-Dien Trinh, MD | Janssen | Meeting Participant or Lecturer |
Mark D. Tyson, MD | ||
Ramakrishna Venkatesh, MD | Retrophin Inc | Consultant or Advisor |
Julian Hsin-Cheng Wan, MD | Allergan | Scientific Study or Trial |
Journal of Urology | Health Publishing |
Accreditation: The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation: The American Urological Association designates this enduring material for a maximum of 24.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other Learners: The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.
AUA Disclosure Policy: All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) participating in an educational activity provided by the AUA are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.
Resolution of Identified Conflict of Interest: All disclosures will be reviewed by the program/course directors or editors for identification of conflicts of interest. Peer reviewers, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:
- Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director, editor, and/or Education Conflict of Interest Review Committee or its subgroup
- Limit content to evidence with no recommendations
- Introduction of a debate format with an unbiased moderator (point- counterpoint)
- Inclusion of moderated panel discussion
- Publication of a parallel or rebuttal article for an article that is felt to be biased
- Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
- Divestiture of the relationship by faculty
Evidence-based Content: It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.
Off label or Unapproved Use of Drugs or Devices: It is the policy of the AUA to require the disclosure of all references to off-label or unapproved uses of drugs or devices prior to the presentation of educational content. The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.
Disclaimer: The opinions and recommendations expressed by faculty, authors, and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the AUA.
Release Date: Issue month, 2019.
Expiration Date: Issue month, 2022.
Price
IF YOU ARE RENEWING YOUR SUBSCRIPTION, PLEASE LOG IN TO SEE YOUR RATE AND PURCHASE OR DOWNLOAD THE JOURNAL OF UROLOGY® VOLUMES 201/202 HOME STUDY COURSE (2019) ORDER FORM.